Description
Anti-CEACAM5 (Labetuzumab) -CL3-SN-38 ADC | ADC-W-384 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-CEACAM5 monoclonal antibody conjugated via a CL3 linker to a SN-38
Status: In stock
Expected Delivery Time: 9-11Weeks